[Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01)].
We carried out a survey of supportive care at institutions that participated in the JBCRG01 study (FEC followed by docetaxel) as neoadjuvant therapy for operable breast cancer. The purpose was to share the information of supportive care for the treatment effect of perioperative intensive chemotherapy among institutions. Appropriate supportive care for nausea, vomiting, edema and febrile neutropenia (FN) is important with respect to the safety of chemotherapy. According to the results of the questionnaire, support from the family and the relationships with doctors, nurses and pharmacists familiar with the chemotherapy were important. The equipment and service for outpatients' cancer chemotherapy center are also important. This multicenter study enhances the exchange of information among institutes. The results of this survey suggest that adequate supportive care makes anthracycline and taxane chemotherapy manageable in the outpatient setting.
Masuda
Norikazu
N
Dept. of Surgery, Osaka National Hospital.
Toi
Masakazu
M
Takatsuka
Yuichi
Y
Nakamura
Seigo
S
Iwata
Hiroji
H
Ohno
Shinji
S
Kuroi
Katsumasa
K
Kusama
Mikihiro
M
Hisamatsu
Kazufumi
K
Yamazaki
Kosuke
K
Eisei
Shin
S
Sato
Yasuyuki
Y
Kaise
Hiroshi
H
Kashiwaba
Masahiro
M
Iwase
Hirotaka
H
Kurosumi
Masafumi
M
Tsuda
Hitoshi
H
Akiyama
Futoshi
F
D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects*; D003625:Data Collection; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy